FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management

Up | AC What's New | AC Home

Food and Drug Administration

  Oncologic Drugs Advisory Committee
March 13, 2006

  MORNING SESSION

Briefing Information

Food and Drug Administration

Disclaimer

Portions of these documents may have been determined to be exempt from disclosure under the Freedom of Inoformation Act (the FOIA) (5 U.S.C. §552). These redacted portions will appear as white space on the screen or on the printed page.

FDA Backgrounder March 13. (a.m. Session)

AFTERNOON SESSION

  Eli Lilly & Company - Briefing Material

The statements contained in this document(s) are not those of the FDA, and the FDA does not necessarily agree with these statements. FDA has not made a final determination about the issues to be discussed at the Advisory Committee Meeting.

Gemzar ® Briefing Material

Food and Drug Administration

Disclaimer

Portions of these documents may have been determined to be exempt from disclosure under the Freedom of Inoformation Act (the FOIA) (5 U.S.C. §552). These redacted portions will appear as white space on the screen or on the printed page.

FDA Gemzar ® Review

Bibliography


FDA/Dockets Management